Daraxonrasib (RMC-6236) is an orally effective and novel triple complex RAS (ON) MULTI inhibitor, which is a potent non covalent inhibitor of multiple RAS variants in GTP binding state. RMC-6236 has anti-tumor activity and can be used in research related to RAS driven tumors. With rich experience in compound synthesis, we can provide fast customized synthesis services for this product according to your research needs.

811.05

C44H58N8O5S

99.8%

CCN1C(C2=C([C@H](C)OC)N=CC(N3CCN(C)CC3)=C2)=C2CC(C)(C)COC(=O)[C@@H]3CCCN(N3)C(=O)[C@@H](NC(=O)[C@H]3C[C@@H]3C)CC3=NC(=CS3)C3=CC2=C1C=C3

DMSO: 200.00 mg/mL (246.59 mM), Sonication is recommended.

Keep away from moisture,Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准